Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 11 November

Paulina Peters
November 11, 2021

Morning Bell 10 November

Sophia Mavridis
November 10, 2021

Morning Bell 9 November

Paulina Peters
November 9, 2021

Morning Bell 8 November

Sophia Mavridis
November 8, 2021

Weekly Wrap 5 November

Sophia Mavridis
November 5, 2021

Morning Bell 4 November

Paulina Peters
November 4, 2021

Morning Bell 3 November

Sophia Mavridis
November 3, 2021

Morning Bell 2 November

Paulina Peters
November 2, 2021

Morning Bell 1 November

Sophia Mavridis
November 1, 2021

Weekly Wrap 29 October

Sophia Mavridis
October 29, 2021

Morning Bell 28 October

Paulina Peters
October 28, 2021

Morning Bell 27 October

Sophia Mavridis
October 27, 2021